Evidence map›Paper›PMID 32634357›Full record

ArticleHealth affairs (Project Hope)2020

Cost-Effectiveness Of A Workplace Ban On Sugar-Sweetened Beverage Sales: A Microsimulation Model.

Sanjay Basu, Laurie M Jacobs, Elissa Epel, Dean Schillinger, Laura Schmidt

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health affairs (Project Hope), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Healthy Food Service Guidelines for Worksites and Institutions: A Scoping Review.International journal of environmental research and public health · 2025
    Article
  6. Simulated retail food environments: A literature review of systems science approaches to advance equity in access to healthy diets.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Sanjay BasuSanjay Basu (sanjay_basu@hms.harvard.edu) is director of research and population health at Collective Health, in San Francisco, California, and a faculty member at the Center for Primary Care, Harvard Medical School, in Boston, Massachusetts.
Laurie M JacobsLaurie M. Jacobs is a researcher at the Institute for Health Policy, University of California San Francisco (UCSF), in San Francisco, California.
Elissa EpelElissa Epel is a professor of psychiatry at UCSF.
Dean SchillingerDean Schillinger is a professor of general internal medicine at UCSF.
Laura SchmidtLaura Schmidt is a professor of health policy in the School of Medicine and holds a joint appointment in the Philip R. Lee Institute for Health Policy Studies and the Department of Anthropology, History, and Social Medicine, all at UCSF.
Electronic Product Services (Czechia) · CZGeneral Dynamics (United States) · USHarvard Pilgrim Health Care · USThe Centre for Health (New Zealand) · NZUniversity of San Francisco · US

Funding

ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Testing combinations of population interventions to encourage healthy eatingR01DK116852 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHILLINGER, DEAN · 2018 to 2022
$3.7M
NCCDPHP CDC HHS U18 DP006526NCRR NIH HHS M01 RR001271NIDDK NIH HHS P30 DK092924NIDDK NIH HHS P30 DK098722NIDDK NIH HHS R01 DK116852
6 · The paper itself

Abstract

Sugar-sweetened beverages (SSBs) increase chronic disease risk. We estimated the impact on employee health and health care spending of banning SSB sales in California-based health care organizations. We used survey data from a large, multisite health care organization in California, sampling 2,276 employees three months before and twelve months after a workplace SSB sales ban was imposed. We incorporated the survey data into a simulation model to estimate chronic disease incidence and costs. We estimated that an SSB ban as effective as the one observed would save about $300,000 per 10,000 people over ten years among similar employers, as a result of averted health care and productivity spending-after both SSB sales losses and non-SSB beverage sales gains were accounted for. Sales bans would typically need to reduce SSB consumption by 2.2 ounces per person per day for lost revenue to be fully offset if there were no increase in non-SSB beverage sales.

Indexed as

Sugar-Sweetened BeveragesBeveragesCommerceCost-Benefit AnalysisHumansSweetening AgentsWorkplaceSweetening AgentsCoronary heart diseaseCostg-effectivenessDental diseaseDiabetesDiseasesHealth policyKidney diseaseNational Health and Nutrition Examination SurveyObesityOccupational healthSugar sweetened beveragesWorkplace wellness

Identifiers

PMID32634357
PMCPMC7968436
OpenAlexW3040033713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.